Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,262.56 89.32 0.55%
S&P 500 1,842.98 12.37 0.68%
NASDAQ 4,034.16 11.47 0.29%
Ticker Volume Price Price Delta
STOXX 50 3,122.70 31.18 1.01%
FTSE 100 6,567.50 25.89 0.40%
DAX 9,253.60 79.89 0.87%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Cyberonics To Report Fiscal Year 2014 First Quarter Results And Host Webcast And Conference Call On August 22, 2013

 Cyberonics To Report Fiscal Year 2014 First Quarter Results And Host Webcast
                    And Conference Call On August 22, 2013

PR Newswire

HOUSTON, Aug. 8, 2013

HOUSTON, Aug. 8, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today
announced that the company will report financial results for the first quarter
ended July 26, 2013, of its fiscal year ending April 25, 2014, on Thursday,
August 22, 2013, before regular market trading hours.  The company will
conduct a conference call to discuss those results on the same day at 8:00 AM
Central Time (9:00 AM Eastern Time).

Fiscal Year 2014 First Quarter Results Webcast and Conference Call
The conference call will be available to interested parties through a live
audio webcast in the Investor Relations section of Cyberonics' corporate
website at  To listen to the conference call live
by telephone, dial 877-638-4557 (if dialing from within the U.S.) or
914-495-8522 (if dialing from outside the U.S.).  The conference ID is

Within 24 hours of the webcast, a replay will be available under the "Events &
Presentations" section of the Investor Relations portion of the Cyberonics
website, where it will be archived and accessible for approximately 12 months.

About Cyberonics, Inc. and the VNS Therapy^® System
Cyberonics, Inc. is a medical technology company with core expertise in
neuromodulation.  The company developed and markets the VNS Therapy System,
which is FDA-approved for the treatment of refractory epilepsy and
treatment-resistant depression.  The VNS Therapy System uses a surgically
implanted medical device that delivers pulsed electrical signals to the vagus
nerve. Cyberonics markets the VNS Therapy System in selected markets

Additional information on Cyberonics and the VNS Therapy System is available

Contact Information
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main:  (281) 228-7262
Fax:  (281) 218-9332

SOURCE Cyberonics, Inc.

Sponsored Links
Sponsored Links